Question 1

How big is the Global Anthrax Immune Globulin market?

Accepted Answer

According to Value Market Research, the Global Anthrax Immune Globulin market size was estimated at USD 465.92 Million in 2025 and is expected to reach USD 505.42 Million in 2026.

Question 2

What is the Global Anthrax Immune Globulin market growth?

Accepted Answer

The Global Anthrax Immune Globulin market is expected to grow at a CAGR of 8.48% from 2026-2034 to reach USD 969.29 Million by 2034.

Question 3

Which country holds the highest share in the Global Anthrax Immune Globulin market?

Accepted Answer

North America held the highest share in the Global Anthrax Immune Globulin market.

Question 4

How is the Global Anthrax Immune Globulin market segmented in the report?

Accepted Answer

The Global Anthrax Immune Globulin market is segmented By Product Type (Anthrax Immune Globulin Intravenous, Monoclonal Antibody Therapy), By End-User (Hospitals & Emergency Care Centers, Pharmaceutical & Biotechnology Companies, Others).

Question 5

Who are the key players in the Global Anthrax Immune Globulin market?

Accepted Answer

Some key players include Emergent BioSolutions, Elusys Therapeutics, GC Biopharma, Cangene Corporation (now part of Emergent BioSolutions) and Pfizer Inc..

Global Anthrax Immune Globulin Market Size, Share, Trends & Growth Analysis Report Segmented By Product Type, (Anthrax Immune Globulin Intravenous, Monoclonal Antibody Therapy), End-User, And Regions (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), 2026-2034